Right on Fouremm. Instead of essentially repeating the same news release from December (but this time citing a 2 week old publication), perhaps their news release could have addressed one of the following pending questions I have sent to Sarah:

Will the results of the SSRA be announced or will Resverlogix keep them confidential?

Will the BIO International slides be posted? 

Is Resverlogix still blinded in BETonMACE? 

Is the apabetalone dosing period in BETonMACE 104 weeks as stated previously or did it change as suggested in Dr. Kalantar-Zadeh's recent ERA-EDTA poster to up to 36 months?